Treatment of obesity with liraglutide in cardiovascular prevention: Case series by the “ITACARE-P Light-Heart Lab” working group

IF 1.9 Q3 PERIPHERAL VASCULAR DISEASE

International Journal of Cardiology Cardiovascular Risk and Prevention Pub Date : 2024-06-01 DOI:10.1016/j.ijcrp.2024.200272

Francesco Maranta , Francesca Buffoli , Vittorio Giudici , Gabriella Malfatto , Alessandro Maloberti , Luigi Maresca , Bruno Passaretti , Anna Torri , Roberto Turato , Marco Ambrosetti

引用次数: 0

查看原文本刊更多论文

利拉鲁肽治疗肥胖症，预防心血管疾病：ITACARE-P轻型心脏实验室 "工作组的病例系列

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

International Journal of Cardiology Cardiovascular Risk and Prevention Cardiology and Cardiovascular Medicine

CiteScore

3.00

自引率

0.00%

发文量

审稿时长

72 days